AxoGen Inc
AXGN
View Detailed Chart
35.170USD
+0.150+0.43%
Market hours （ET）Quotes delayed by 15 min
1.62BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.43%
5 Days
+1.30%
1 Month
+13.45%
6 Months
+177.58%
Year to Date
+7.45%
1 Year
+93.14%
View Detailed Chart
TradingKey Stock Score of AxoGen Inc
Currency: USD Updated: 2026-02-02Key Insights
AxoGen Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 3 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 36.60.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
AxoGen Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
AxoGen Inc Highlights
StrengthsRisks
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 35.18% year-on-year.
Undervalued
The company’s latest PE is -837.40, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 42.08M shares, increasing 0.02% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 2.15K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 2.01.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
36.600
Target Price
+5.02%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
AxoGen Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
AxoGen Inc Info
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
Ticker SymbolAXGN
CompanyAxoGen Inc
CEODale (Michael Donald)
Websitehttps://www.axogeninc.com/
Related Instruments
+0.39%
+0.20%
-0.84%
-0.06%
-0.45%
+0.64%
+1.06%
+1.76%
+0.85%
+1.80%
+0.65%
+1.30%
+0.03%
+2.09%
+2.04%
+1.43%
+0.27%
-1.17%
+0.80%
+0.26%Popular Symbols
269.988
-0.022 (-0.01%)
181.190
-4.420 (-2.38%)
77407.510
-561.130 (-0.72%)
272.420
+2.190 (+0.81%)
2267.000
-52.160 (-2.25%)
420.820
-0.990 (-0.23%)
4938.160
+286.440 (+6.16%)
62.511
+0.511 (+0.82%)
1.180
+0.001 (+0.06%)
155.809
+0.226 (+0.14%)
